Mettler-Toledo International Inc. (MTD) Earnings Call Transcript & Summary
May 31, 2023
Earnings Call Speaker Segments
Wei Deng
executiveHello, everyone. Welcome to today's Transform Productivity with Automated Sampling online seminar. My name is Wei Deng, the Market Manager at Mettler-Toledo. I'm excited for today's talk, and I would like to thank you and the presenters for your participation in today's event. A bit of housekeeping before we get started. Please submit your questions via chat. We will address them in order of when they come in. Any questions that aren't addressed in today's session will be given to the presenter and answered directly after the event. Our first talk today is from Brian Seifried with Bristol Myers Squibb. The title of the presentation is Application of EasyFrit for Crystallization Process Design and Optimization. Dr. Brian Seifried received his PhD in Chemical Engineering from MIT. His thesis work focused on creating mucin mimetic materials using a combination of synthetic biology and polymer chemistry within the Olsen research group. Currently, he is a senior scientist in the Materials Science and Engineering group at BMS, where he works API crystallization process development as well as investigates enabling technologies. Please start with the presentation, Dr. Seifried.
Brian Seifried
attendeeHello, everyone. My name is Brian Seifried. And on behalf of my colleagues at BMS, I'd like to thank you for coming to my talk today. The title of my talk is Application of EasyFrit for Crystallization Process Design and Optimization. And I'll be telling you 3 brief little stories about this exciting new invention that Mettler-Toledo was so kind to let us beta test at BMS. And so before I get into the main topic of my talk, I'd like to make sure everybody is on the same page and talk a little bit about the solution phase in active pharmaceutical ingredient or API crystallization. So crystallization itself is one of the most commonly used isolation and purification of the active ingredient in your drugs. And this is because it provides great control over the form, purity and powder properties of your crystals. That being said, there is a whole host of information contained within the solution phase for crystallization. The way this solution phase is typically analyzed within the industry is through high-performance liquid chromatography where you take an aliquot of your solution, dilute it in some sort of diluent and then run it through a liquid column where the different components within the sample are separated based off of differences in properties. And then this is detected and can quantify the different species and solution. And this is super useful for crystallization process design because this lets you understand the desaturation or essentially, what's the concentration of your API and solution and let you know how well your crystallization is working as well as the impurity part or essentially how good is your crystallization at getting rid of your unwanted impurities. That being said, collecting the solution phase within a crystallization is not so straightforward. So crystallizations are characterized by being a 2-phased system. There's your solid phase, which is hopefully your pure crystal and then the liquid phase, which has everything else ranging from the impurities, solvents and your dissolved API. And that being said, HPLC does not handle solid-liquid mixtures very well. So what you end up having to do, at least within a standard practice within the industry is actually taking an aliquot of your reactor and then syringe filtering it. This ends up being a very time- and labor-intensive process that's very difficult to automate just because of the filtering component. And so this is where the engineers and scientists at Mettler-Toledo came up with a very incredible update to their automated liquid sampling system. They have a product known as the EasySampler, which essentially allows scientists to take liquid aliquots of their reactor vessel at predetermined times and thus automating the liquid sampling. The previous limitation to this sample though was a function of how it's designed. They can only handle homogenous liquids and did not handle 2-phase systems or crystallizations very well. This is because the way the probe works is it's inserted into your crystallization vessel, that probe is actually closed in the beginning, and at set intervals, the probe head will open up, liquid to flow into the probe and then it's diluted with various quenched or diluent solvents. However, they created a brand-new product that we were so fortunate to investigate and look at BMS, lovingly dubbed the EasyFrit. The EasyFrit system essentially is a filter frit attachment that goes on to the EasySampler probe. What happens is in solution, when the probe head actually goes out of solution, it depresses -- or extends a spring, which forces solution through the filter frit into the reaction packet and thus keeping all the unwanted solids outside the filter frit and then letting the solution phase go into your frit, thus letting you not clog up the filter -- clog up your EasySampler and still be able to collect samples from your 2-phase system for your crystallization. So like all good scientists, we had BMS got this brand-new toy and hearing how it's essentially too good to be true, had it run some validation tests. See if this is actually as good as the manual method. And so what we did is we took some acetaminophen, dissolved it in a 3:1 acetone water and measured the solubility both with manual poles as well as EasySampler poles. And we did each of these in triplicate. What we found is that the EasyFrit and manual poles are in good agreement for the solubility values and thus giving us enough of a leg to stand on for using this for our own crystallization process development experiments. So now that we got everybody on the same page, I'll get into the 3 little stories like I said. The theme of the first story is temperature. So crystallization itself typically works on taking advantage of the difference in solubility. And there's different ways of accomplishing the difference in solubility between 2 time points of your API. You can either use an anti-solvent addition, you can use evaporation or you can use a temperature-based crystallization. Just because [Technical Difficulty] called on your reaction or your vessel, it tends to come out of solution. But this creates a unique challenge when you're interested in taking liquid samples at higher temperatures. Just because if you remember, the main way of preparing your HPLC samples for understanding your liquid phase is manually filtering it. And so if your manual filter is at room temperature, but your reactor is at like 50, 60 degrees Celsius, it becomes a little bit of a challenge. The best practice within industry is typically to try to put all your syringes, filters, miles, everything in a glass oven to try to get the same temperature as your reaction vessel, and then pull things out of the oven, filter as quickly as possible and hope not too much of your API's crash out solution from the ensuing temperature drop. Just because it's essentially impossible to get temperature of the reaction vessel, as you carried across the room or into your hood. And so this became an issue for this experiment I was actually running earlier this year. I was running a cooling crystallization with a seed age at 70 degrees Celsius. And so I wanted to understand [Technical Difficulty]. However I was running this experiment with manual poles, I was as getting non-sensible data. If you direct your attention to this graph, you will notice that the solubility line are at around 120 mg API per gram solvent is a lot higher than the solubility or API concentration values I was getting when I was doing my manual poles. This made absolutely zero sense considering how the solution was a slurry and clearly supersaturated. And so I was kind of stuck. My colleagues recommended giving the EasyFrit a world and I succeeded in my experiment. When I reran the experiment with the EasyFrit, I was able to get API concentrations that actually makes sense. It's about solubility and value of the API and was slowly going down. This information has allowed me to start designing the seed age for my crystallization and essentially saved us from a lot of guesswork in super conservative estimates for seed age given the inability to collect useful data. Now the second story revolves around the concept of efficiency. So this story goes along with one of my colleagues who specializes in modeling crystallizations. One of the major tenets of modeling work is that there is a relationship between the accuracy of your model and the amount of resources and time you put into it. And typically, it's some sort of positive relationship. The more time and effort you throw into it, generally, the more accurate it is. That being said, [Technical Difficulty] models, there's some range where the results are actually acceptable if it's too far off from reality, your model is fairly useless. So the issue is that since we're engineers, we believe time is money, and we're always looking for ways of doing things better. And our end goal is always to try to improve the relationship of the resources and time we put into our model and its general efficiency. So this is a very cool to say that my colleague was able to do. She was trying to build a model for a different crystallization system. And she was looking to fit the parameter, I believe, the order in respect of supersaturation. She had begun with a very small data set. She had run 2 experiments, getting tired of setting up everything over and over again, and then she has had a little Eureka moment. She thought what if I just set up one experiment, put in the EasyFrit and just thermocycled my reactor, letting the crystals come in and out over and over again, maybe like 2 or 3 times. This way, I can get 3 extra desaturation curves for the price of setting up one experiment instead of having to come in and set up an experiment, clean up, set up in the next one and repeat. And what she found is a significant improvement in the model fit, both in terms of estimating the actual value as well as the standard deviation of the fit. That being said, she is a very responsible scientist, and she had to go and validate her EasyFrit iterative experiment by having to go and do those 3 extra experiments. But for the benefit of this talk, at least, we were able to get a head-to-head comparison and how effective her EasyFrit iterative experiment was. It turns out that her 3-for-1 deal experiment was just as good as running 3 additional experiments in terms of creating a model. And it just shows that the EasyFrit system itself gives a lot of opportunity for designing creative ways of maximizing your data output from single experiments. And so this brings us to the last story I want to talk to you guys today about. The theme of this talk is time. So a very common characteristic of crystallization is that, it typically is a very long and slow process on the order of hours, if not more, just because the way the molecules need time to orderly pack themselves in solution among other things. And so this creates some unique challenges, especially within the industrial setting for crystallizations that last longer than the workday. It's because the way that you typically run a crystallization and if it's a very long one, is you set it up in the morning, collect samples throughout the day, go home for the evening, come back in the next morning and say, "Hey, my crystallization is probably done", collect 1 or 2 last samples and just roll with it. But the issue is that, that type of schedule doesn't scale up when you go to the plant situation. Those are typically 24/7 operations, and they're going to want to know, hey, let's say, we are running to cooling crystallization. And the cooling graph is done. Do we need to hold it? Or can we just go with the isolation step? Problem is that if you're running this cooling ramp in the lab setting, you'll be like, "I have no idea. I'm at home. This is your cooling ramp finished at midnight." So we guess we need an 8-hour cooling or hold after this, but we have no data proving this. And sadly or ironically, this situation happened to one of our colleagues. So he was running a slow cooling crystallization at 0.1 Celsius per minute. And so based off of such a gentle cooling rate, we assumed that the desaturation was being reached at the end of the cooling ramp. And so his data looked a little bit like this. He set up the reaction in the morning or crystallization in the morning, the seed age would go, he'd be collecting the samples regularly, and then he just collected a couple of samples throughout the day before heading home. And then in the morning, he'd come in, collect one last sample, see it is completely desaturated. But that being said, we had no clear idea of how long this sample -- or if the sample is truly desaturated at the end of the cooling ramp, since this is happening while we are at home. Turns out when we got our hands on the EasyFrit, we reran the crystallization and were able to collect the data after the end of the cooling ramp and made a very surprising discovery. We found out that even though we're very gentle and very slow with the cooling ramp, our API is still not desaturating. And there's actually a noticeable amount of API still within solution. This was the basis of a series of follow-up experiments where we were able to collect more data overnight and determine an appropriate holding period after the end of the cooling crystallization and saved us a lot of headache when -- if there was like a major mismatch between the yield on the lab scale versus the plant scale. And so that concludes the 3 stories I wanted to tell you guys today. Just briefly recapping their highlights. The EasyFrit has shown itself that it can actually be superior to sampling at elevated temperatures just because the probe is already within the reaction fluid and at the temperature. So there's no temperature drop during sampling. My colleague was able to show that you can develop some very clever experiments for maximum data output using the EasyFrit and its automated nature. And lastly, I wanted to show that the EasySampler and EasyFrit together allows for the streamlining of data sampling, especially at odd hours and long hold points. And so with that, once again, on behalf of my colleagues at Bristol Myers Squibb, I'd like to thank you guys, the audience for your time and attention. And I'd like to open the floor to questions now.
Wei Deng
executiveYes. Thank you, Brian, for the presentation and recommendations. Now we open Q&A for Brian's presentation. Brian, can you open your mic.
Brian Seifried
attendeeYes. Can you hear me?
Wei Deng
executiveYes. I can hear you, Brian. So yes, so the first question is EasySampler with EasyFrit saves resources and time compared to traditional best practice, as you mentioned in the presentation. Can you roughly quantify how many -- how much experiment is saved?
Brian Seifried
attendeeSo it saves a lot of your personal time in the term of babysitting your crystallization because if you need a data point every 30 minutes, that means you're essentially tied to that reactor. I mean you can have some in between rest periods, but it's very difficult to set up something more time consuming, whereas with like the EasyFrit you can literally just get everything set up in a couple of hours in the morning and then go about your day and instead more reactions, more crystallizations, going to meetings, it frees up a whole lot of bandwidth. So it essentially turns an all-day event into a couple of hour event in the morning.
Wei Deng
executiveYes. So essentially talk about it saves a lot of -- increases your productivity overall, right?
Brian Seifried
attendeeYes.
Wei Deng
executiveOkay. Yes. The second question is, does EasySampler with EasyFrit meet all your sampling needs in crystallization process. That's a very general question.
Brian Seifried
attendeeI'd say it meets about 90%, 95% of the needs. There are certain situations where, I guess, intrinsic limitations exist. One of them is just like the EasySampler does have some minimum dilution levels. So if your samples or your systems has extremely low concentrations, you might be over-diluting your sample and not be able to read it with HPLC, but those are few and far between -- at that point, you can just pick a manual sample. So -- but overall, it's very good from what our experience is.
Wei Deng
executiveYes. There's also another question. Is there a limit in how low of the solvability you can measure towards the end of the crystallization given the subsequent dilution by the EasySampler.
Brian Seifried
attendeeI think my previous response kind of led into this a little bit. But yes, I think the setting for the EasySampler that I was using at BMS had a minimum dilution level or dilution factor of 80. And so there is some API / HPLC limits that did -- that couldn't dilute or couldn't detect the API, when it was diluted by 84 at that point. So that was like usually the very final couple of samples. Normally, at that point, though, it's -- I can just -- I see the mother liquor and take that directly. So...
Wei Deng
executiveYes. Thanks, Brian, for answering all the questions. For our audience, if you still have questions afterwards, please put in your questions in the chat box so that we can direct to Brian afterwards. Thank you, Brian.
Brian Seifried
attendeeThank you.
Wei Deng
executiveYes. So we are moving on to our next talk today is Automated Sampling and LC Analysis of Process Solutions given by Mr. Makoto Michida. Makoto Michida is a process chemist at Daiichi Sankyo for 25 years, with recent interest in lab automation and automating medium-scale synthesis experiments. His expertise and passion for automation have been recognized, and he's expected to contribute to future research in the field. Mr. Michida-san, please start with the presentation.
Makoto Michida
attendeeHi, everyone. Thank you for inviting me to this revenue. My name is Makoto Michida from Daiichi Sankyo, Process Technology Research Laboratory. Today, I'll be talking about development of Automated Sampling and LC Analysis System of Process Solutions. Here's agenda of my presentation today. The first is background, I will provide an introduction on the motivation behind lab automation, especially medium-scale experiments. Next, we will explore automation for qualitative analysis. By connecting the EasySampler with HPLC system to automate sample preparation and injection processes. Then we want to quantitative analysis. We will discuss the challenges that need to be overcome in this area. We have been working to conduct accurate and reproducible quantitative analysis by using of the systems. Lastly, I will summarize the key points of this presentation and emphasize the potential benefits of lab automation for process chemistry. First of all, let me share with you why I am interested in automation of medium-scale experiments. There are 3 main reasons for this. Firstly, medium-scale experiments essential for scaling up all types of projects. Secondly, they take a long time to complete, especially when considering the manufacturing timelines. Lastly, they are suitable for automation due to their predetermined experimental procedures. For these reasons, we have been working on the automation of medium-scale experiment for a few years. We identified that the core technology to achieve this is making [Technical Difficulty]. And we believe that there are 4 key technologies such as addition, sampling and analysis, separation and concentration. Don't need to be developed for this purpose. In this session, let me share with you about the automation of sampling and analysis. Basically, sampling and analysis of process solution is essential for data collection and it frequently performed operation and process development. Example includes reaction monitoring, quantitation in separation and the variation of stability and the concentration condition and quantitation of losses in the filtrate during the crystallization. So you can imagine there are many opportunities in medium-scale experiments. Here is an example of a typical timeline for medium-scale synthesis experiment. As you can see, the process involves sampling, preparation, HP analysis and then data variation. Although each individual operation may just only take a minute, they must be repeated approximately 10x that makes the entire human resources inefficient and nonproductive for researchers. So we came up with the idea of automating these reserve tests. To be more specific, let me show you with the actual procedures. First, we use micropipette to sample 5 to 10 microliters of the process solution, then diluting to 1 millimeter in the vial and set it in the HPLC autosampler and run. After that, we take and analyze the results. As a navigator to somehow automate these operations, we thought about finding a way to directly connect the EasySampler to the HPLC. First, we tried the qualitative analysis by connecting EasySampler to HPLC. Originally, the EasySampler takes 20 microliters of sample, performs automatic programs, planting and division and then transferred to the solution to stop [indiscernible] in the carousel. This equipment is already very useful, but it cannot automate HPLC analysis by itself. So we tried to transfer the prepared solution to the [indiscernible] in HPLC autosampler instead of using the [indiscernible] in the carousel. The [indiscernible] mounted autosampler is provided by [indiscernible] Corporation, and it's totally used for [indiscernible] testing of direct product and flow reactors. We investigated the timing of injection from the sampling and the concentration. This image shows the concentration distribution of the sample in the tube. Initially, the sample is quenched by mixing with the quenching solution, then transfer the mixture by diluting solution to the [indiscernible]. The peak of the sample was supposed to come after approximately 100 seconds from the sampling. This slide shows the relationship between the timing of injection and concentration of the sample. Before testing, we prepared 0.5% of sample solution as a standard and then compared the peak area. If the concentration of the sample was constant, it should be around here. But the result of the distribution was widely changed according to the injection time. As a result, qualitative analysis was possible by time adjustment of injection, but large concentration distribution when low reproducibility of the peak area were observed in the [indiscernible]. Then our focus shifted to quantitative analysis. The challenge lies in how we can consistently prepare the sample solution with a constant concentration. As we mentioned before, it was confirmed that the sample can be transferred from EasySampler to HPLC. Then instead of the [indiscernible], we try to prepare the sample solution by connecting 4-milliliter [indiscernible] in autosampler through a switching [indiscernible]. The sample solution was dispensed by opening the [indiscernible] with accurate duration to prepare the constant concentration samples. The closure timing was adjusted within the range of 50 to 60 seconds, and each analysis was performed with 3x each. And we observed that the peak area closely match the standard sample. However, a few samples degraded from the standard. We attribute this to the position of the diagram pump. But as a result, most of the samples yielded consistent result, [indiscernible] as the optimized condition like this. Next, let me show you the software configuration for automating this entire [indiscernible]. We use eye control for EasySampler and lab solution for [indiscernible] HPLC. Here is an example for conducting 5x sampling and analysis every 2 hours. But first, input the number of repetition in the [indiscernible], in this case, 5x, then put the command for sampling with the dilution factor. In parallel with this, at the same time of the sampling put this command for sending a [indiscernible] signal to the HPLC for 80 seconds. This is very important because the sampler transfer starts afterwards. Then send the [indiscernible] signal to the switching [indiscernible] to transfer the sample solution to the HPLC for 85 seconds to prepare a 0.5% sample solution. Since this process is repeated every 2 hours, include a wait command like this. Regarding double solution, the program consists of 4 methods. The first method is designed to receive the signal from iControl for the following sequence. In the [indiscernible] method, the sample solution is transferred to the [indiscernible]. The [indiscernible] method is to maintain a constant concentration. And finally, the sample is analyzed as usual. Here is an example of tracking reactions every 1 hour. This reaction proceeds through multiple intermediates. So it is difficult to understand what's going on. However, by increasing the sampling frequency through automation, it was possible to follow detailed trends of each product in complex reaction systems. This is also the same reaction. We have variated tracking the reaction yields by quantitative analysis every 1 hour. By using this peak area, targeting the yield by comparing the area of the standard sample. This approach can measure the reaction yield directly without being affected by other peaks. This slide doesn't contain actual data, but this system would be effective for automating these analysis. For example, it can be utilized for quantitative stability test. Also, for the time cost monitoring of the filter rate in crystallization to confirm the endpoint by attaching a filter. In summary, the routine and repetitive operations of sampling and HPLC analysis in process research can be automated by connecting EasySampler and HPLC. Also, we can see the results through remote desktop. So all the operations can be conducted without being on site. Currently, we are actively developing the automation system for medium-scale [indiscernible] experiments. We believe that such a device would be in demand in Euro laboratories as well. If you are interested, please feel free to contact us. We will be delighted to collaborate with you and explore the possibility together. That concludes my presentation. And finally, I'd like to make one more announcement. I am currently serving as an Editorial Advisory Board member for the OPRD Journal, and we are planning to feature a special issue on lab automation. I encourage you all to actively contribute and submit your research to this upcoming issue. Your valuable insights and findings will greatly contribute to the advancement of lab automation. Thank you for your attention.
Wei Deng
executiveThank you, Michida-san for the presentation and recommendations. Now we open for Q&A for Michida-san's presentation. Michida-san, can you open your mic?
Makoto Michida
attendeeSure.
Wei Deng
executiveYes. Michida-san, thank you for staying online. I know it's very late in Japan. Now we -- so the first question is what was the biggest bottleneck in this approach towards the next level of automation.
Makoto Michida
attendeeSo -- what does it mean?
Wei Deng
executiveYes. So what was the -- so I think the question is about, if you want to reach the next level of lab automation, as you mentioned in the presentation, what was the still the biggest bottleneck in your mind.
Makoto Michida
attendeeSo -- that's a great question. But I'm currently trying to lab automation. So the biggest problem is automatic separation and solid handling. So it's very difficult.
Wei Deng
executiveYes. So you say that the biggest bottleneck that in your mind is the separations in solid handling.
Makoto Michida
attendeeYes.
Wei Deng
executiveOkay. Yes. Thank you. Yes, the next question is automated routines can help scientists work more efficiently than manual operation. Approximately how many resources and time were saved by adopting the new method, as you mentioned in the presentation.
Makoto Michida
attendeeYes. I think it's -- normally, we are doing the routines around 10x a day. So it -- so maybe we can keep 5 hours to keep the time for other research or something -- meeting or something like that.
Wei Deng
executiveRight. It actually also increased your work productivity in the environment, right?
Makoto Michida
attendeeYes.
Wei Deng
executiveYes. And just also another personal question from my side that it's in Daiichi Sankyo that you plan to widely utilize this methodology in this -- the direct injunction.
Makoto Michida
attendeeNow I'm just -- I'm trying for automation, but hopefully, it will be used for all the researchers.
Wei Deng
executiveYes, that will be great. And yes, solving the -- some bottlenecks, yes?
Makoto Michida
attendeeYes.
Wei Deng
executiveOkay. Thank you for answering all the questions, Michida-san. Yes, so we will -- for the audience that -- if you have further questions for Michida-san, please still put into the chat, and we will pass to Michida-san even after the session. Yes. Thank you, Michida-san.
Makoto Michida
attendeeThank you.
Wei Deng
executiveSo our final talk today is Process Development and Characterization of an Acutely Hazardous Reaction through Data Reach Experimentation presented by Taylor Behre. Taylor graduated with her Bachelor of Science in Chemical Engineering from Purdue University in 2018. She then began her career in the pharmaceutical industry at Merck, where she has worked for almost 5 years. During her time at the company, she has worked on both early and late-stage process research and development. Specifically, Taylor has experience in process optimization, characterization and scale-up of small molecule active pharmaceutical ingredients from fab to commercial scale. Currently, Taylor works in MEC pilot plan as a process engineer in Rahway, New Jersey. Please start with the presentation, Taylor.
Taylor Behre
attendeeHi, everyone. My name is Taylor Behre. I work in process research and development at Merck in Rahway, New Jersey. And today, I'll be discussing the process development and characterization of an acutely hazardous reaction through data-rich experimentation. Now with any process that's in development, our goal is to gain as much knowledge as we can from our experiment, which we do through strategic sampling. And this knowledge we gain is intended to inform optimization and scale up of our processes. And so with hazardous processes, we have the same goal but with some added considerations and the big one is safety. And we use the hierarchy of controls, which is shown here on the slide. We're obviously getting rid of the hazard is the most desirable, but that's not always possible. So in that situation, the question becomes, how do we make sure we're operating safely while studying a representative process at the same time. So today, we'll be talking about Merck's nemtabrutinib program, which is an active pharmaceutical ingredient or API in our oncology pipeline. Its synthesis is highly convergent, bringing together 2 chains, the end of which are shown on the slide to generate the nemtabrutinib API. One of the penultimate steps in the synthesis, which we call the acetal opening step is particularly hazardous. It uses boron trifluoride etherate and trifluoroethylene reagents to perform a reductive acetal ring opening to generate the immunoalcohol [indiscernible] intermediate. Now originally, this combination of reagents was chosen based on literature reviews to avoid the formation of hazardous diborane gas. And to confirm this, NMR studies were performed on the reaction. And ultimately, these studies did find that diborane is present in the process, as shown by the pink line on the graph. And what we found was that, first, the formation of diborane is delayed after both boron trifluride and trifluoroethylene reagents have been added to the reactor. Secondly, there is an induction period with no conversion to product until after formation of diborane, as shown by the red and the blue dots. And third, diborane concentration decreases and is not detected at end of reaction. Through all of these observations, we were able to conclude that diborane is formed by the mechanism shown at the bottom of the slide, and it is actually the active reducing agent in this reaction. Now this is important because suddenly we went from having a process that was fairly safe to a process that is absolutely not safe into 2 once the reaction begins. As I mentioned, diborane is very hazardous. It is highly flammable, toxic and reactive. And through headspace IR studies, we determined that the process generates levels of diborane well above any acceptable limits listed on the slide. Specifically, we were concerned with the toxicity levels where the amount of diborane that is immediately dangerous to life and health is only 15 ppm. So we started looking at getting rid of it. We were looking at souping it out of the reactor headspace with nitrogen to keep the levels of diborane below any of the levels listed here. And you can see from the graph in the center of the slide that, that didn't work. We were seeing significant negative impacts to both conversion and purity. So then we looked at running the reaction under pressure to contain diborane within the reactor. And that gave us great results. Levels of our key dimer impurity were lower than ever and full conversion was achieved consistently, which wasn't honestly surprising given diborane's role as the active reductant. So this then gave us line of sight to development and scale up. So to quickly summarize everything unique that we knew about the reaction at this time, first, from the NMR studies, we know we have a multistage nonlinear reaction. We also know we have gas generation, and I already talked about diborane, but we also have hydrogen generation. From the blue line in the center graph, you can see there are 2 stages of pressure generation. The first slower increase is hydrogen being generated by the boron trifluride etherate reagent reacting with residual water in the system. And once that residual water is consumed, we have a large pressure spike in conjunction with an exotherm, which is related to diborane formation. As we discussed, we also run this reaction under pressure to contain more of the gases, which adds complexity to the system. And finally, to top it off, this reaction is multiphase. Some of the starting material remains solid at the beginning of the reaction, and it dissolves as the reaction progresses. Also trifluoroethylene is immiscible in the solvent system. So this makes up the top liquid phase and the rest of the solvents and reagents make up the second liquid phase. And of course, we have the gases, which have their own solubilities in the liquids, which creates an equilibrium as we run this under pressure to contain the gases. As a little bit of a side note, we did use Dynochem to model the mixing of the system and to design various mixing studies. And from these, we did identify a mixing sensitivity where higher levels of impurities were produced when the 2 liquid levels were not well mixed. And our control strategy moving forward was to ensure that our agitation rate was always at or above the liquid's just disperse speed. So we did continue to use Dynochem to model the system in every reactor throughout all tech transfers and scale-ups. So now getting back to our main development goal for any process, we wanted to be able to profile the reaction to understand the kinetics more and how they're impacted by various factors. But with such a complicated process and all the other challenges that are shown on this slide, we were asking ourselves how do we safely collect representative samples from our experiments without disturbing the headspace equilibrium at all. So to answer that question first of all, we know that we're going be running the samples in labs and we will be using the pressure reactors. And when [Technical Difficulty], you would first start by putting some pressure on the reactor. And as I mentioned, we do operate [Technical Difficulty] and we would want to sample under that much pressure [Technical Difficulty]. So we have to vent some of that pressure. We would [Technical Difficulty] line to collect the samples [indiscernible] under pressure and lower the line back into the reactor to clear [indiscernible]. That really is a great option on process for multiple reasons. First, the fluctuations in pressure are going to alter the gas liquid equilibrium inside of the reactor. And from our previous studies, we know that, that is not desirable and also not representative of our ideal process. And second, but even more importantly, is the safety aspect. We do not want to be handling diborane containing samples under any circumstances given the low toxicity limits. So the solution to this was actually to use an EasySampler, which can be programmed to take institute samples from a probe that's inserted into the reactor and it's also able to immediately quench those samples as well to stop the reaction from proceeding, and it allowed us to maintain constant pressure in the reactor and to avoid handling diborane. And in addition, since we understood the mixing from our Dynochem model, we were also confident that we're getting wellness and representative samples. So we then created a development plan to help achieve the goal of getting them a complete process understanding. And the factors that we looked at in this plan included reagent charges, reaction temperature, solvent ratio and water content. And we chose our targets and ranges based on previous process knowledge as well as some range finding experience. For the sampling plan, which is shown in the second table on the slide, we knew the EasySampler could do programmed to take 12 samples before having to manually switch out the sample vials. And we wanted to spread those 12 samples across the entire reaction age while also concentrating them around the diborane-generation event, where we were seeing the fastest reaction rates. From previous experiments, we were noticing that the reaction temperature was significantly impacting the timing of that diborane-generation event, where lower reaction temperatures were leading to longer induction periods with no conversion to product and vice versa for high temperatures. So looking at the early sampling times in this table, you can see how the samples were concentrated based on reaction temperature in an effort to capture the end of that induction period and the beginning of conversion to products. And when we ran these experiments at the EasySampler, we were able to generate data like that shown in the graph on the right. where we tracked starting material, product, pressure and dimer impurity levels. Now this is a graph for only one experiment. So we had a lot of data. And in starting to approach the analysis of the data, we had 2 main goals. The first was that we wanted to be able to accurately predict the induction time and the onset of the diborane generation event. And the second was that we wanted to determine when to call end of reaction at scale. So starting with the first goal, predicting the induction time is important because of the pressure spike and the conjunctive exotherm related to the diborane generation. Having an accurate estimate of this event would be able to enable a more efficient process control at scale and would also provide the manufacturing sites with more confidence in the robustness of this process. So to accomplish this goal, we started off by calculating an apparent induction time for each experiment. The graph on the left shows data from 2 separate experiments, one of which was performed at a higher reaction temperature in red and 1 at a lower temperature in blue. And these 2 experiments together show just how much the induction time can vary as the process parameters differ, which emphasizes the importance of creating a predictive tool. The graph also shows the induction times calculated based on the intersection of the slopes of the induction period and the initial reaction rate. We then took the calculated induction times and regressed them against the previously mentioned factors, reagent charges, solvent ratio, et cetera. And the graph on the right shows a contour plot of 2 factors, water and reaction temperature, which were found to have a statistically significant impact on the induction time. This graph shows that high water content and low reaction temperatures produced the longest induction times. And we were able to use this analysis and this data to successfully aid in predicting the onset of the pressure spike and the exotherm at scale, which I'll get into in a bit more detail in a couple of slides. Now for the second goal, understanding time to end of reaction is important, especially for such a hazardous reaction. As I mentioned previously, diborane is completely consumed during the process and is not present at end of reaction. So we want to be able to call the end of reaction at an appropriate time to avoid early intervention, while diborane may still be present. So to determine how to call end of reaction, we actually didn't focus on the key dimer impurity because it stops forming after time. So if we stop the reaction too early, we only have lower dimer, which is a good thing. And if we stop it too late, it doesn't matter so much for the impurity because it plateaus anyway. In addition to that, the highest levels of dimer that we saw in these experiments actually passed all of our specifications. So instead, we decided to focus on the starting material and reaction conversion. We plotted all of the starting material data collected with the EasySamplers by temperature, as shown in the graph on the left of the slide. The red points represent 4 experiments run at high temperature. The green are 4 at target temperature and the blue are 4 experiments at low temperature. And the different shaped markers also show each individual reaction at that temperature. And despite the variation in kinetics, the experiments all had acceptable conversion below the maximum starting material rejection capability after 16 hours. This knowledge enabled us to implement a control strategy that did not require and in process control at end of reaction. So instead, we set an acceptable range for the reaction age time between 18 and 24 hours, and we were able to avoid relying on a sample altogether. When we did implement this at scale for the first time, we only took one sample after the reaction age time for information only, and we were able to proceed on to the next unit operation without pausing for data analysis. And also, this was only for development purposes and moving forward beyond that, no samples will be needed during or at the end of reaction. This strategy [Technical Difficulty] is able to [indiscernible] a robust process. And although not in the scope of this talk, the [indiscernible] strategy also saves time as we don't have to wait for sample results. And this is important to us because we do have another impurity that grows in over time, which is why we did set an upper limit of 24 hours on this reaction age time. So at this point, currently, we've scaled up this process for more than 10 batches, but the graph on this slide shows the pressure reaction temperature and jacket temperature trends for the first 3 scale-up batches that we performed. And with our induction time predictor tool, we were able to estimate the diborane-generation event. Looking at the dotted black line marking the pressure onset in each of these graphs, the delay between these and the decrease in jacket temperature marked by the open circles is shorter for each batch, which shows improved jacket temperature response time at each batch. This is important when considering that the maximum desired batch temperature is 50 degree of Celsius. And you can see in Batch 1, where there was a bit of a longer delay in jacket response time, how much more of the batch temperature rose due to that exotherm. And when I say delay, I really only mean a couple of minutes temperature. Then as jacket response time was improved with the ability to predict the induction time with each batch, we gained more control of the exotherm which you can see in batches 2 and 3. And in addition to the improvements in prediction of the induction time, the table at the bottom left shows the consistency in the final conversion and end of reaction for these 3 batches, which supports our reaction age time control strategy. And the understanding around the induction time and end of reaction that we gained from our characterization did enable the successful, safe and robust scale-up of the acetal opening process here. So finally, to summarize, safety played a major role in defining our process. We were able to implement our control strategy and gain enhanced process understanding from data-rich experimentation that enabled a safer process. In addition to these improvements, we also implemented various controls at all scales for added safety. So going back to the hierarchy of controls shown on the right of the slide, we implemented engineering controls in the form of diborane monitors, administrative controls in the form of training for both typical operations and potential upset scenarios and also PPE controls. And the robust process and successful scale-up were a result of a highly collaborative effort from Merck's Safety in engineering departments and our enhanced knowledge from data-rich experimentation enabled consistent processing at various scales to produce greater than 200 kilos of immunoalcohol [indiscernible] intermediate across multiple batches throughout development so far. Just a few acknowledgments and a big thank you to the entire team. And thank you to everyone for attending, and I can take any questions now.
Wei Deng
executiveThank you, Taylor, for the presentation and recommendations. Now we open Q&A for Taylor's presentation. Taylor, can you open your mic?
Taylor Behre
attendeeYes. Can you hear me okay?
Wei Deng
executiveYes. Perfect. Thank you, Taylor. First question is from understanding to control, to scale up, what was the most challenging and time-consuming part of this study?
Taylor Behre
attendeeThat's a good question. Probably, the most challenging and time consuming, I would probably say that the initial discovery of the diborane itself was probably the most challenging. So once we discovered that, safety immediately became the top priority. So that was kind of time consuming things paused for a little bit as we tried to make sure that we were operating safely, both at lab scale and anywhere else. So I'd say that was definitely the most challenging part.
Wei Deng
executiveYes, I can also feel it when you -- throughout your presentation was a surprise. Yes. Okay. The second question is how to balance the modeling in SKU analysis and off-line HPLC analysis in terms of efficiency and productivity from a data reach perspective?
Taylor Behre
attendeePart of balance that.
Wei Deng
executiveYes, how to -- so he's mentioning that in your presentation, you were mentioning about modeling in SKU analysis and offline HPLC analysis using EasySampler? And how -- I think the question means how to balance those different methods in terms of efficiency and productivity from a data reach perspective?
Taylor Behre
attendeeSo the EasySampler was a major help with balancing the productivity of that. So we were able to collect 12 samples for every experiment. So we had a lot of data. So that really gave us a full picture of what the kinetics of our reactions looked like and was able to give us a much better understanding of our process. I would say kind of a bottleneck in that process is the analysis itself, so the HPLC analysis of those samples. So pretty much each morning, we were coming back to 12 samples ready for analysis. And then the modeling itself, the productivity of the modeling itself, the data organization was probably the biggest thing to balance there and just getting that into the correct format to begin the modeling itself. I hope that answers the question.
Wei Deng
executiveYes, I think, yes, because you -- if I'm understanding correct that you use a lot of different analytical methods and toolings to bring this whole process. And the question really, I mean, wants to know that like in terms of you using a tool, where do you spend most of the time? And where do you think it's the time well spent, it's being efficient. Yes. I guess that's what it's about. Yes. But yes, but you answered it already. Yes, I don't see more questions, but yes, for audience, if you still have questions, and we are still able to receive questions even after the presentation. Yes. Thank you, Taylor, for staying with us.
Taylor Behre
attendeeThank you.
Wei Deng
executiveYes. We are at the end of the today's seminar. Thank you for -- thank you again for all of today's speakers, Brian, Michida-san and Taylor for the excellent talks. Links to the recorded presentation from this seminar and the past events will be e-mailed to you probably by the end of the week. Again, if you have any questions, please send them via chat, and we will pass them to the speakers, and they will get back to you. If you joined today's seminar, you may be interested in future events. At July 26, we have a PAT for bioprocess optimization. At September 27, we have sustainable chemistry. At October 25, we have a continuous flow process optimization and control. If you visit mt.com/ac-saminars for more information, you'll find a lot of information there. If you have any feedback for today's event, please complete our survey by scanning the QR code or tapping the link. Thank you, everyone, for joining today's seminar. I hope you enjoyed it. Have a good rest of the day. Thank you.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Mettler-Toledo International Inc. transcript — plus 248,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Mettler-Toledo International Inc. earnings transcripts and 248,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.